Company Description
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology.
It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more.
In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels.
The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021.
LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1994 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 307 |
| CEO | Justin Schreiber |
Contact Details
Address: 236 Fifth Avenue, Suite 400 New York, New York 10001 United States | |
| Phone | 866 351 5907 |
| Website | lifemd.com |
Stock Details
| Ticker Symbol | LFMD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000948320 |
| CUSIP Number | 53216B104 |
| ISIN Number | US53216B1044 |
| Employer ID | 76-0238453 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Justin Schreiber | Chairman and Chief Executive Officer |
| Dennis Wijnker | Chief Technology Officer |
| Shane Biffar | Chief Compliance Officer and Deputy General Counsel |
| Marc Benathen | Chief Financial Officer |
| Eric H. Yecies | Chief Legal Officer, General Counsel and Corporate Secretary |
| Jessica Friedeman | Chief Marketing Officer |
| Stefan Galluppi | Chief Innovation Officer |
| Nicholas P. Alvarez | Chief Acquisition Officer and Head of Customer Acquisition |
| James Porte | Senior Vice President of Patient Experience |
| Gerard Rotonda III | Managing Director of Strategy and Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 6, 2025 | 10-Q | Quarterly Report |
| May 6, 2025 | 8-K | Current Report |
| Apr 29, 2025 | 144 | Filing |
| Apr 29, 2025 | 8-K | Current Report |
| Apr 28, 2025 | ARS | Filing |
| Apr 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 28, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 25, 2025 | 8-K | Current Report |
| Mar 11, 2025 | 10-K | Annual Report |
| Mar 10, 2025 | 8-K | Current Report |